Genetic polymorphisms in the CYP1A1 and CYP1B1 genes and susceptibility to bladder cancer: a meta-analysis (Q35144348)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

6 August 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Genetic polymorphisms in the CYP1A1 and CYP1B1 genes and susceptibility to bladder cancer: a meta-analysis (English)

1 reference

6 August 2017

Yan-Zhi Chen

1

1 reference

6 August 2017

Jing Li

2

1 reference

6 August 2017

Yu-Xia Zhao

3

1 reference

6 August 2017

Dan Liu

4

1 reference

6 August 2017

He-Tong Wang

5

1 reference

6 August 2017

Ya Gao

6

1 reference

6 August 2017

Ying Chen

7

1 reference

6 August 2017

publication date

10 April 2014

1 reference

Molecular Biology Reports

6 August 2017

published in

1 reference

6 August 2017

volume

41

1 reference

6 August 2017

issue

8

1 reference

6 August 2017

page(s)

4929-4940

1 reference

Bladder cancer epidemiology and genetic susceptibility

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

Antitumor activity of a duocarmycin analogue rationalized to be metabolically activated by cytochrome P450 1A1 in human transitional cell carcinoma of the bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

CYP1A2 polymorphisms, occupational and environmental exposures and risk of bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

High-order interactions among genetic variants in DNA base excision repair pathway genes and smoking in bladder cancer susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

Environmental factors and genetic susceptibility promote urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

Polymorphic variation of CYP1A1 and CYP1B1 genes in a Haryana population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

In silico studies of polyaromatic hydrocarbon inhibitors of cytochrome P450 enzymes 1A1, 1A2, 2A6, and 2B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

Cytochrome P450 1A1-mediated anticancer drug discovery: in silico findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

LINE-1 hypomethylation is associated with bladder cancer risk among nonsmoking Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

Contributions of human enzymes in carcinogen metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

Role of CYP1B1 gene polymorphisms in bladder cancer susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

Comparison of two methods to detect publication bias in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

Coffee consumption, genetic susceptibility and bladder cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

Metabolism and Biomarkers of Heterocyclic Aromatic Amines in Molecular Epidemiology Studies: Lessons Learned from Aromatic Amines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

Is CYP1A1 induction always related to AHR signaling pathway?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

The function of cytochrome P450 1A1 enzyme (CYP1A1) and aryl hydrocarbon receptor (AhR) in the placenta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

The role of aryl hydrocarbon receptor in regulation of enzymes involved in metabolic activation of polycyclic aromatic hydrocarbons in a model of rat liver progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

Cytochrome P1B1 (CYP1B1) polymorphisms and ovarian cancer risk: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11033-014-3359-3

CYP1A1 (Ile462Val), CYP1B1 (Ala119Ser and Val432Leu), GSTM1 (null), and GSTT1 (null) polymorphisms and bladder cancer risk in a Turkish population

21 January 2018

1 reference

12 December 2020

CYP1A1 gene polymorphisms as a risk factor for pterygium

1 reference

12 December 2020

Association between polymorphisms in the biometabolism genes CYP1A1, GSTM1, GSTT1 and GSTP1 in bladder cancer

1 reference

12 December 2020

Genetic linkage mapping of the CYP11A1 gene encoding the cholesterol side-chain cleavage P450scc close to the CYP1A1 gene and D15S204 in the chromosome 15q22.33-q23 region

1 reference

12 December 2020

Expression of pigment epithelium-derived factor in bladder tumour is correlated with interleukin-8 yet not with interleukin-1α

1 reference

12 December 2020

Genetic polymorphisms in CYP1A1, CYP1B1, COMT, GSTP1 and NAT2 genes and association with bladder cancer risk in a French cohort.

1 reference

12 December 2020

The ability of hydroxylated estrogens (2-OH-E2 and 4-OH-E2) to increase of SHBG gene, protein expression and intracellular levels in MCF-7 cells line

1 reference

12 December 2020

Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes

1 reference

12 December 2020

[Effects of CYP1A1 and GSTM1 gene polymorphisms and BPDE-DNA adducts on lung cancer]

1 reference

12 December 2020

HEGESMA: genome search meta-analysis and heterogeneity testing

1 reference

12 December 2020

The effect of CYP1A1 and GSTM1 gene polymorphisms in bladder cancer development in a Turkish population

1 reference

12 December 2020

Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk.

1 reference

12 December 2020

Interaction ofN-(2-Hydroxypropyl)methacrylamide Copolymer-Doxorubicin Conjugates with Human Liver Microsomal Cytochromes P450: Comparison with Free Doxorubicin

1 reference

12 December 2020

10.1007/S11033-014-3359-3

Identifiers

DOI

1 reference

6 August 2017

1 reference